Access and practical information.
We organize the available sources and note details to confirm directly with the clinic before making care or travel plans.
Visiting & getting startedEssential planning details
- Location
- Cologne, Germany
- Referral and intake guidance
- Confirm the current intake process, clinical eligibility and whether a referral is required.
Costs & coverageQuestions to confirm
- Costs and estimates
- IOZK's dedicated therapy-cost page lists indicative fees of €6,800–€8,500 for pre-treatment laboratory tests, €23,000–€26,000 per IO-VAC cycle (at least two cycles), and €6,000–€11,000 for a five-day additional treatment unit. Additional medicines or antibody therapy are excluded. Its FAQ lists different laboratory and cycle ranges. These are clinic-published estimates, not an individual quote; request a current written itemized estimate and confirm what is optional or additional.
- Coverage and authorization
- IOZK says its immunotherapy is not ordinarily covered by German statutory health insurance, although case-by-case applications may be possible. Some private insurers or other payers may reimburse according to contract. The clinic says patients are responsible for treatment costs regardless of reimbursement; confirm coverage and payment terms before travel.
Clinical & organizational informationCredentials and scope
- Care team and credentials
- Confirm the clinician responsible for care and their current professional registration.
What to know about this center.
Centre and care setting
IOZK describes an outpatient treatment centre with examination rooms and its own diagnostic and manufacturing laboratories at Hohenstaufenring 30–32 in Cologne. Its program is individualized rather than a fixed course, and this profile does not imply that the same interventions are available or suitable for every cancer.
Program and evidence
IOZK describes IO-VAC as a patient-specific dendritic-cell vaccine used within its broader immuno-oncology program. Its treatment-process page says the plan may be coordinated with surgery, radiation or chemotherapy. IOZK's FAQ says it has no comparative clinical trials from which to derive statistical efficacy for its own program. The National Cancer Institute describes dendritic-cell vaccines as a research area; its approved sipuleucel-T vaccine is a different product for selected advanced prostate cancer. These facts do not establish the effectiveness of IO-VAC for an individual diagnosis.
Consultation and planning
The clinic says the first consultation reviews medical history and existing findings, including conventional options. It describes a subsequent blood test, internal tumor conference and discussion of a proposed plan. IOZK's contact page invites consultation requests by email. The exact documents, tumor-material requirements and timing for a particular patient should be confirmed directly with the clinic.
Costs and insurance
The clinic publishes indicative fees for testing, vaccination cycles and some additional treatment units, but its dedicated costs page and FAQ do not give identical ranges. Individual medicines and some antibody treatments may add charges. German statutory insurance generally does not include this immunotherapy; private reimbursement or an exception requires case-specific confirmation. A current itemized written estimate is needed for a meaningful comparison.
Contact and travel
IOZK lists Hohenstaufenring 30–32, 50674 Cologne, Germany, telephone +49 221 420 399 25 and info@iozk.de. Its contact page asks prospective patients to email for a consultation. Appointment availability, visit duration, language support and lodging arrangements were not independently confirmed for this profile.
Reported treatments & supportive services
These connections come from Cancer Clinic Finder research, clinic-confirmed selections, or both. Open a guide to learn more and discover other clinics reporting the same approach.
Sources
Source information checked: 2026-11-01. The links below identify the public and clinic-provided materials used for this page.
- IOZK — treatment centre and facilities ↗Checked 2026-11-01
- IOZK — treatment process and initial consultation ↗Checked 2026-11-01
- IOZK — indicative therapy costs and reimbursement ↗Checked 2026-11-01
- IOZK — FAQ, costs and evidence limitations ↗Checked 2026-11-01
- IOZK — contact and consultation request ↗Checked 2026-11-01
- National Cancer Institute — cancer treatment vaccines ↗Checked 2026-11-01
How Cancer Clinic Finder compiles information · Suggest a factual correction
